amyotrophic

M2 PHARMA-August 16, 2019-Neuropore Receives Orphan Drug Designation for NPT520-34 for the Treatment of Amyotrophic Lateral Sclerosis

ENPNewswire-August 15, 2019--Neuropore Receives Orphan Drug Designation for NPT520-34 for the Treatment of Amyotrophic Lateral Sclerosis August 14, 2019

Pharmaceutical company Aquestive Therapeutics Inc (NASDAQ:AQST) said on Tuesday that it has successfully filed a New Drug Application (NDA) with the US Food and Drug Administration (FDA) for the investigational product riluzole oral film (ROF) for the treatment of amyotrophic lateral sclerosis (ALS).

With the recent discontinuation of aducanumab in mild Alzheimer's disease, the company's amyotrophic lateral sclerosis anti-sense oligonucleotide programs could help dispel the notion that Biogen has no pipeline, Raymond tells investors in a research note.

Background: Ongoing efforts have been made to identify new neuroimaging markers to track amyotrophic lateral sclerosis (ALS) progression.

A Keio University research team will begin clinical tests for the treatment of amyotrophic lateral sclerosis (ALS), administering ALS patients an existing drug used for another disease, which is confirmed to be effective in experiments with induced pluripotent stem (iPS) cells.

[ClickPress, Thu Sep 27 2018] Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles.

CytRx's milestone payment follows the dosing of the first patient under the Phase 3 clinical trial evaluating arimoclomol in patients with amyotrophic lateral sclerosis (ALS).

The patent covers the use of ISC-hpNSC, ISCO's proprietary neural stem cells derived from human parthenogenetic stem cells, for the treatment of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis.

GERMANTOWN, Md., May 3, 2018 -- Comparison of data from combined cohorts in Phase 1 and 2 clinical trials versus historical controls validates plans for additional trials to evaluate benefits of using neural stem cells to treat amyotrophic lateral sclerosis, or ALS, Neuralstem said.

He was, simultaneously, a source of inspiration for both scientists and patients of amyotrophic lateral sclerosis (ALS).